Browse Category

Stock Market News 13 November 2025

IREN Stock Falls on November 13 as Market Questions Earnings Quality After Record Q1 and $9.7B Microsoft AI Cloud Deal

IREN Stock Falls on November 13 as Market Questions Earnings Quality After Record Q1 and $9.7B Microsoft AI Cloud Deal

Shares of IREN Limited (NASDAQ: IREN) – the bitcoin‑miner‑turned‑AI‑data‑center operator – are sliding today as fresh commentary about the “quality” of its blockbuster earnings collides with a sharp technical sell‑off after last week’s euphoria around its $9.7 billion Microsoft AI cloud contract. IREN+2Reuters+2 Below is a breakdown of what is moving IREN today and how it fits into the bigger AI‑cloud story investors have been watching all month. Key takeaways What’s happening to IREN stock today? A big gap‑down open and heavy early trading According to MarketBeat’s real‑time alert, IREN closed Wednesday at $55.70, then opened Thursday at $52.75, with early
13 November 2025
D-Wave Quantum (QBTS) Stock Plunges as Short Sellers Circle and Institutions Buy – All the Key News on 13 November 2025

D-Wave Quantum (QBTS) Stock Plunges as Short Sellers Circle and Institutions Buy – All the Key News on 13 November 2025

As of Thursday, 13 November 2025, D-Wave Quantum Inc. (NYSE: QBTS) is back in the spotlight – and not in a calm way. The quantum computing pioneer’s stock is sliding sharply again, even as big-name investors file new stakes and the media debate whether the recent boom in quantum stocks is a bubble or a once‑in‑a‑generation opportunity. Below is a full, news-style roundup of all the major D-Wave–related stories hitting today (13 November 2025), plus the context from last week’s Q3 earnings that’s driving the volatility. QBTS stock today: double‑digit drop after a year of explosive gains As of the
Nokia (NOK) News Today, November 13, 2025: Nvidia’s $1B Stake Closes as AI, 5G and Sustainability Push Stock Higher

Nokia (NOK) News Today, November 13, 2025: Nvidia’s $1B Stake Closes as AI, 5G and Sustainability Push Stock Higher

Nokia Oyj is back in the global spotlight today as a wave of AI‑focused news, a completed $1 billion Nvidia investment, fresh 5G deals and new sustainability milestones all land on the same date. Here’s everything that matters for Nokia (NOK) on 13 November 2025. NOK stock today: steady near recent highs Nokia’s U.S.-listed ADR (ticker NOK) was recently trading around $7.03, up about 0.1% on the day, with an intraday range of $7.005–$7.22. That keeps the stock close to levels reached after Nvidia’s investment was first announced in late October, when the shares jumped more than 20% and hit
Circle Internet Group (CRCL) Stock Today: JPMorgan Upgrade, Ark Invest Buy-the-Dip and New StableFX Launch Shape Post‑Earnings Rebound

Circle Internet Group (CRCL) Stock Today: JPMorgan Upgrade, Ark Invest Buy-the-Dip and New StableFX Launch Shape Post‑Earnings Rebound

Circle Internet Group (NYSE: CRCL), issuer of the USDC stablecoin, is back in focus today after a bruising post‑earnings sell‑off. As of this afternoon on 13 November 2025, CRCL is trading around $86.44, with an intraday range roughly between $83.94 and $88.81 and heavy volume of about 29 million shares, more than double typical trading activity. Investing.com Investors are digesting three big storylines: CRCL Stock Tries to Find a Floor After 12% Plunge Circle’s stock has had a wild 24 hours. On Wednesday, 12 November, CRCL dropped around 12% to close at $86.30, its steepest single‑day fall since late June
Light & Wonder (LNW) Completes Nasdaq Delisting as ASX CDI Listing, New ESPP and Governance Filings Go Live – 13 November 2025

Light & Wonder (LNW) Completes Nasdaq Delisting as ASX CDI Listing, New ESPP and Governance Filings Go Live – 13 November 2025

Light & Wonder, Inc. has officially wrapped up its U.S. primary listing era. The gaming and iGaming group has now completed its long‑flagged Nasdaq delisting, shifted its capital‑markets home to the Australian Securities Exchange (ASX), refreshed its employee stock purchase plan and pushed through a wave of governance and debt filings — all converging around today’s 13 November 2025 milestone. explore.investors.lnw.com+1 Key takeaways Nasdaq delisting lands – and index providers catch up Light & Wonder first told investors in October that it would voluntarily delist its common stock from Nasdaq and consolidate its primary listing on the ASX. The company
13 November 2025
Stock Market Today, Nov. 13, 2025: Dow Slides as Disney Plunges and Tech Stocks Drop After Trump Ends Record Shutdown

Stock Market Today, Nov. 13, 2025: Dow Slides as Disney Plunges and Tech Stocks Drop After Trump Ends Record Shutdown

Dow Jones pulls back from a fresh record above 48,000 as Wall Street digests the end of the longest U.S. government shutdown, a sharp Disney sell-off, and renewed pressure on Big Tech. Market overview: Wall Street takes a breather after record highs U.S. stocks traded lower on Thursday, November 13, 2025, as investors pivoted from celebrating fresh records to worrying about what comes next for the economy and interest rates. By early trading, the major indexes were down across the board: The pullback comes just one day after the Dow jumped more than 300 points to close around 48,254, its
13 November 2025
Cellebrite (CLBT) Soars on Q3 2025 Earnings Beat, Raised Guidance and Fresh Analyst Upgrades

Cellebrite (CLBT) Soars on Q3 2025 Earnings Beat, Raised Guidance and Fresh Analyst Upgrades

Digital intelligence specialist Cellebrite DI Ltd. (Nasdaq: CLBT) is jumping on Thursday, November 13, 2025, after posting stronger‑than‑expected third‑quarter results and lifting its 2025 outlook, prompting multiple bullish calls from Wall Street. CLBT stock jumps as investors digest Q3 beat Cellebrite shares are rallying sharply in today’s session. As of mid‑afternoon trading on November 13, CLBT is changing hands around $19.80, up roughly 24% from the pre‑earnings close, on heavy volume. Benzinga Pre‑market, the stock was already up more than 20%, after the company reported better‑than‑expected Q3 2025 numbers and raised its full‑year guidance, drawing trader attention to the name.
13 November 2025
Sealed Air (SEE) Soars to 52‑Week High as Clayton Dubilier & Rice Weighs Take‑Private Deal

Sealed Air (SEE) Soars to 52‑Week High as Clayton Dubilier & Rice Weighs Take‑Private Deal

Sealed Air Corporation (NYSE: SEE), maker of Bubble Wrap, jumped to a 52‑week high on November 13, 2025, as private‑equity firm Clayton Dubilier & Rice reportedly explores a take‑private deal. Here’s what’s driving SEE stock today, including fresh buyout rumors, Q3 2025 earnings, analyst targets, and key risks. Sealed Air Corporation (NYSE: SEE) is suddenly one of Wall Street’s hottest tickers. The packaging company behind Bubble Wrap and Cryovac is rallying sharply today after multiple reports that private‑equity giant Clayton, Dubilier & Rice (CD&R) is exploring a takeover that could take Sealed Air private. By late morning on Thursday, SEE
Outlook Therapeutics (OTLK) Soars as FDA Accepts ONS‑5010 BLA and Sets December 31, 2025 Review Date

Outlook Therapeutics (OTLK) Soars as FDA Accepts ONS‑5010 BLA and Sets December 31, 2025 Review Date

Outlook Therapeutics (NASDAQ: OTLK) shares jumped today after the U.S. FDA accepted the company’s resubmitted Biologics License Application (BLA) for ONS‑5010/LYTENAVA, its bevacizumab-based eye drug for wet AMD, and set a PDUFA review date of December 31, 2025. Here’s what investors need to know. What Outlook Therapeutics announced today This morning, Outlook Therapeutics, Inc. (NASDAQ: OTLK) announced that the U.S. Food and Drug Administration has accepted the company’s resubmitted Biologics License Application for ONS‑5010 (bevacizumab‑vikg)/LYTENAVA, its investigational ophthalmic formulation of bevacizumab for the treatment of wet age‑related macular degeneration (wet AMD). GlobeNewswire+2Outlook Therapeutics+2 According to the company’s press release and
Clearmind Medicine (CMND) Stock Soars as FDA‑Regulated Alcohol Use Disorder Trial Expands to Hadassah – November 13, 2025

Clearmind Medicine (CMND) Stock Soars as FDA‑Regulated Alcohol Use Disorder Trial Expands to Hadassah – November 13, 2025

Vancouver / Jerusalem – November 13, 2025 – Shares of Clearmind Medicine Inc. (NASDAQ: CMND), a clinical‑stage psychedelic and neuroplastogen biotech company, jumped sharply on Thursday after the firm announced final approval to expand its FDA‑regulated Phase 1/2a clinical trial for Alcohol Use Disorder (AUD) to Hadassah Medical Center in Jerusalem. GlobeNewswire+1 At the same time, Clearmind filed a new Form 6‑K detailing a registered direct offering of shares and pre‑funded warrants, adding fresh capital but also raising dilution questions for investors. Stock Titan Below is a full breakdown of today’s key developments and what they mean for CMND stock.
13 November 2025
Manulife (MFC.TO) Hits Record High on Q3 Beat, India Mahindra JV and $350M Longevity Push

Manulife (MFC.TO) Hits Record High on Q3 Beat, India Mahindra JV and $350M Longevity Push

Manulife Financial Corporation (TSX: MFC, NYSE: MFC) has packed a full strategic reset, fresh Asian expansion, and a record quarter of earnings momentum into just a couple of days — and the market is cheering. Shares of Manulife jumped as much as 3.3% today to an all‑time high of C$49.82 in Toronto after the Canadian insurer beat Q3 estimates, unveiled a refreshed growth strategy, and confirmed a 50:50 life‑insurance joint venture in India with Mahindra & Mahindra. Reuters+1 Below is a full rundown of everything investors need to know about Manulife’s news flow around 13 November 2025 — from earnings
13 November 2025
Nebius (NBIS) Stock Slides After Q3 2025 Earnings: $3B Meta AI Deal, Microsoft Pact and CoreWeave Rivalry, Explained

Nebius (NBIS) Stock Slides After Q3 2025 Earnings: $3B Meta AI Deal, Microsoft Pact and CoreWeave Rivalry, Explained

Nebius Group (NASDAQ: NBIS) has just delivered one of the most dramatic weeks in the AI‑infrastructure trade: Today, November 13, Nebius shares are trading back in the high‑$80s, down around 6% intraday and more than 30% off recent highs near $140, even after a year in which the stock has more than quadrupled. StockAnalysis+2MarketBeat+2 At the same time, rival AI “neocloud” player CoreWeave is also under pressure after slashing capital‑expenditure guidance and trimming its 2025 outlook, forcing investors to choose which high‑growth, high‑spend AI infrastructure story they trust more. Investors.com+2Business Insider+2 Here’s what’s really driving Nebius stock today, why some
VisionSys AI (VSA) Crashes Nearly 78% After $12 Million Direct Offering as Shareholders Head Into High‑Stakes Vote

VisionSys AI (VSA) Crashes Nearly 78% After $12 Million Direct Offering as Shareholders Head Into High‑Stakes Vote

VisionSys AI Inc. (NASDAQ: VSA) has become one of Wall Street’s most talked‑about micro‑caps after its shares collapsed nearly 78% in a single session, wiping out most of its recent gains and putting fresh scrutiny on the company’s aggressive capital‑raising and crypto‑treasury ambitions.StockAnalysis+1 As of early Thursday trading, the stock is hovering around $0.28 with heavy volume, slightly below Wednesday’s close at $0.29, keeping VisionSys firmly among the market’s biggest losers heading into a crucial extraordinary general meeting (EGM) scheduled for today in New York.Fast Edgar Archive Stock in Freefall: From Micro‑Cap Momentum to Nasdaq’s Worst Performer VisionSys AI’s collapse
DLocal (DLO) Stock Tumbles After Record Q3 2025 Earnings and New WhatsApp Remittance Push

DLocal (DLO) Stock Tumbles After Record Q3 2025 Earnings and New WhatsApp Remittance Push

Uruguay-based fintech DLocal Limited (NASDAQ: DLO) is having a volatile week. After closing 2.34% higher at $14.86 on Wednesday following record third‑quarter 2025 results, the stock is down around 9% on Thursday, November 13, trading near $13.5 in late-morning New York, as investors focus on margin pressure and softer economics in key markets. Parameter+1 At the same time, DLocal has announced a high‑profile stablecoin-funded WhatsApp remittance partnership with Félix, underlining its push deeper into cross-border payments and crypto rails across Latin America. FF News | Fintech Finance DLO stock: From earnings pop to post-earnings hangover Despite today’s drop, DLocal shares
TNL Mediagene (TNMG) Stock Explodes on Coupang Deal: What Today’s Partnership Means for Taiwan’s Content Commerce Boom – 13 November 2025

TNL Mediagene (TNMG) Stock Explodes on Coupang Deal: What Today’s Partnership Means for Taiwan’s Content Commerce Boom – 13 November 2025

TNL Mediagene (NASDAQ: TNMG) is back in the spotlight today after unveiling a strategic partnership with U.S. Fortune 150 technology and e‑commerce company Coupang, Inc. (NYSE: CPNG), focused on the fast‑growing Taiwan market. PR Newswire The Tokyo‑headquartered digital media and data group says the alliance is designed to supercharge its Content Commerce and Retail Media Network ecosystem across a suite of premium media brands, from The News Lens to Business Insider Taiwan and iCook. PR Newswire Investors have reacted with enthusiasm. As of mid‑morning on November 13, 2025, TNMG shares were trading around $0.44, up roughly 46% on the day,
13 November 2025
Gambling.com Group (GAMB) Stock Crashes After Record Q3 2025 Earnings and Guidance Cut

Gambling.com Group (GAMB) Stock Crashes After Record Q3 2025 Earnings and Guidance Cut

Gambling.com Group Limited (GAMB) delivered record third‑quarter 2025 revenue and adjusted EBITDA before the U.S. market opened on Thursday — but a cautious outlook and ongoing search-traffic headwinds sent the affiliate marketing and sports data stock plunging more than 20% in early trading. Investing.com Canada+3Business Wire+3Business Wire+3 By mid‑morning, GAMB was trading near $5.08, down roughly 25–26% on the day and more than 70% below its 52‑week high around $17, according to live quote data and analyst dashboards. StockAnalysis+1 Below is a full breakdown of everything investors need to know about Gambling.com’s Q3 2025 results, today’s guidance update, and what
Rubico Inc. (RUBI) Stock Slides Again After $84 Million Fleet Refinancing — All the Key Updates for 13 November 2025

Rubico Inc. (RUBI) Stock Slides Again After $84 Million Fleet Refinancing — All the Key Updates for 13 November 2025

Rubico Inc. (NASDAQ: RUBI), the tiny Greek crude‑oil tanker owner that only began trading on Nasdaq in August, is back in the spotlight today after closing a major $84 million fleet refinancing — and still seeing its stock sink around the $0.20 level. Investing.com Australia+1 The company has wrapped up sale‑and‑leaseback deals on both of its Suezmax tankers with a Chinese financier, freeing up roughly $10.4 million in cash after repaying older debt. Yet RUBI shares remain near all‑time lows after a bruising, highly dilutive $7.5 million public offering earlier this month. Investing.com Australia+2Investing.com+2 Below is a full, investor‑focused roundup
13 November 2025
Sonder Holdings (SOND) Nears Chapter 7 After Marriott Split: Stock & Bankruptcy Update for November 13, 2025

Sonder Holdings (SOND) Nears Chapter 7 After Marriott Split: Stock & Bankruptcy Update for November 13, 2025

Sonder Holdings Inc. (NASDAQ: SOND), once pitched as a tech‑driven rival to Airbnb and a partner of Marriott International, is now in full collapse mode. The company is winding down operations, expecting to file for Chapter 7 bankruptcy of its U.S. business and begin insolvency proceedings abroad, while guests around the world report being told to leave their rooms with only hours’ notice. 6abc Philadelphia+3Yahoo Finance+3Stock Titan+3 SOND stock today: extreme volatility under 25 cents As of this afternoon (Nov. 13, 2025), SOND stock is trading around $0.17, up modestly on the day but still hovering near all‑time lows after
13 November 2025
Mangoceuticals (MGRX) Soars on Eli Lilly and Novo Nordisk Deal as It Launches MangoRx Direct for Obesity Drugs

Mangoceuticals (MGRX) Soars on Eli Lilly and Novo Nordisk Deal as It Launches MangoRx Direct for Obesity Drugs

Mangoceuticals, Inc. (NASDAQ: MGRX), the tiny telehealth company best known for its MangoRx men’s wellness brand, is suddenly at the center of the red‑hot obesity drugs market after unveiling a partnership with Eli Lilly and Novo Nordisk to offer official access to their blockbuster GLP‑1 weight‑loss medications Zepbound and Wegovy.GlobeNewswire+1 What Mangoceuticals announced today In a press release and accompanying SEC Form 8‑K filed Thursday, Mangoceuticals said it has launched two integrated programs — MangoRx Direct and PeachesRx Direct — built around official access to GLP‑1 obesity drugs from Eli Lilly and Novo Nordisk.GlobeNewswire+2SEC+2 Under the new model: Mango is
13 November 2025
Stratasys (SSYS) Q3 2025 Earnings: Revenue Slips, Cash Flow Strengthens as 3D Printing Leader Reaffirms 2025 Outlook

Stratasys (SSYS) Q3 2025 Earnings: Revenue Slips, Cash Flow Strengthens as 3D Printing Leader Reaffirms 2025 Outlook

Stratasys Ltd. (NASDAQ: SSYS), a leading player in polymer 3D printing and additive manufacturing, reported third-quarter 2025 results this morning that paint a mixed picture: modestly lower revenue, a sharply wider GAAP loss driven by a non‑cash impairment, but improved cash generation and reaffirmed full‑year guidance. Business Wire+2Business Wire+2 The market is taking the news in stride. After closing at $9.54 per share on November 12, SSYS traded higher in pre‑market and early Thursday action, with at least one report citing a gain of around 7% intraday as investors focused on positive cash flow and a solid balance sheet. Investing.com+3Yahoo
13 November 2025

Stock Market Today

Energy stocks set for a geopolitical week after Iran warning and oil rebound

Energy stocks set for a geopolitical week after Iran warning and oil rebound

7 February 2026
U.S. energy stocks rose Friday, with the S&P 500 energy sector up 1.88% and Exxon Mobil gaining 2.03%. Brent crude settled at $68.05 a barrel after Iran threatened U.S. bases if attacked. Saudi Aramco cut March Arab Light crude prices to a five-year low for Asia. Kazakhstan’s CPC Blend exports may drop 35% this month due to Tengiz oilfield disruptions.
Financial services stocks rally as XLF jumps, Dow hits 50,000 — what to watch next week

Financial services stocks rally as XLF jumps, Dow hits 50,000 — what to watch next week

7 February 2026
U.S. financial stocks rose Friday, with the XLF fund up 1.8% and the Dow closing above 50,000 for the first time, gaining 2.47%. Goldman Sachs jumped 4.3%, JPMorgan 3.9%, and Citigroup 6.0%. The Federal Reserve held rates steady, and San Francisco Fed President Mary Daly signaled possible cuts this year. Investors await January jobs and inflation data next week.
Go toTop